D‑dimer as a potential clinical marker for predicting metastasis and progression in cancer

  • Authors:
    • Hong Dai
    • Hongxing Zhou
    • Yingxin Sun
    • Zhe Xu
    • Shuo Wang
    • Tongbao Feng
    • Ping Zhang
  • View Affiliations

  • Published online on: September 14, 2018     https://doi.org/10.3892/br.2018.1151
  • Pages: 453-457
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

D‑dimer is a widely used biomarker for indicating the activation of coagulation and fibrinolysis, and is reported to serve important roles in cancer progression. The aim of the current retrospective study was to investigate the association of D‑dimer plasma level with the development of various cancers. Patients with breast (n=86), gastric (n=317), pancreatic (n=37), colon (n=153) and rectal (n=137) cancers and 92 healthy volunteers were assessed in the present study. Plasma levels of D‑dimer in the patients and healthy controls were measured by immunoturbidimetric assays. The association of D‑dimer levels with the clinicopathological features of patients were also determined. The plasma levels of D‑dimer were significantly higher in patients with breast cancer (P=0.0022), gastric cancer (P<0.0001), pancreatic cancer (P=0.0003), colon cancer (P=0.0001) and rectal cancer (P=0.0028), compared with the healthy controls. It was also determined that the plasma D‑dimer levels were positively associated with clinical cancer stage (P<0.05) and metastasis (P<0.05). These findings suggested that the plasma D‑dimer level may be used as marker for predicting cancer metastasis and progression.
View Figures
View References

Related Articles

Journal Cover

November-2018
Volume 9 Issue 5

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Dai, H., Zhou, H., Sun, Y., Xu, Z., Wang, S., Feng, T., & Zhang, P. (2018). D‑dimer as a potential clinical marker for predicting metastasis and progression in cancer. Biomedical Reports, 9, 453-457. https://doi.org/10.3892/br.2018.1151
MLA
Dai, H., Zhou, H., Sun, Y., Xu, Z., Wang, S., Feng, T., Zhang, P."D‑dimer as a potential clinical marker for predicting metastasis and progression in cancer". Biomedical Reports 9.5 (2018): 453-457.
Chicago
Dai, H., Zhou, H., Sun, Y., Xu, Z., Wang, S., Feng, T., Zhang, P."D‑dimer as a potential clinical marker for predicting metastasis and progression in cancer". Biomedical Reports 9, no. 5 (2018): 453-457. https://doi.org/10.3892/br.2018.1151